Tansaq Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Tansaq General Information
Description
Developer of preventive healthcare and biomarker analysis technology designed to support health risk assessment and disease prevention. The company develops pre-symptomatic testing, biomarker analysis, and health monitoring technologies, and also provides data analysis, consultation, and contract research services for healthcare and disease risk evaluation applications, enabling individuals and organizations to assess and monitor health-related conditions.
Contact Information
Website
www.tansaq.jpCorporate Office
- 2-3-10 Tenjin Pine Crest 719
- Chuo-ku
- Fukuoka City, 810-0001
- Japan
Corporate Office
- 2-3-10 Tenjin Pine Crest 719
- Chuo-ku
- Fukuoka City, 810-0001
- Japan
Tansaq Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 29-Aug-2025 | Completed | Generating Revenue |
Tansaq Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FASTAR | Accelerator/Incubator |
Tansaq FAQs
-
When was Tansaq founded?
Tansaq was founded in 2022.
-
Where is Tansaq headquartered?
Tansaq is headquartered in Fukuoka City, Japan.
-
What industry is Tansaq in?
Tansaq’s primary industry is Laboratory Services (Healthcare).
-
Is Tansaq a private or public company?
Tansaq is a Private company.
-
What is Tansaq’s current revenue?
The current revenue for Tansaq is .
-
Who are Tansaq’s investors?
FASTAR has invested in Tansaq.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process